Viatris

VTRS | NASDAQ | 28 Followers
$9.32 -0.21% -$0.02
Follow
Overview Metrics Financials
Loading...

Fair Price

$20.84
Undervalued by 37.4%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Viatris Inc. is a pharmaceutical company formed through the merger of two significant pharmaceutical firms. The company specializes in research, development, and manufacturing of prescription medicines, generic drugs, and biosimilars. Viatris offers a broad range of medications for various diseases, from common ailments to serious health conditions. The company is active in the global pharmaceutical market, providing treatment for millions of patients worldwide. Viatris focuses on improving accessibility and affordability of medicines and providing quality alternative treatment options. The company also invests in research for new drugs and treatment approaches to better address patients' healthcare needs. Viatris Inc. (VTRS) shares are an interesting choice for investors who follow the pharmaceutical sector and seek investment opportunities in a global pharmaceutical company with an extensive portfolio of medicines and research activities.

Feed

>3y
Read More

Meilleur, plus rapide, moins cher - et il n'y en a que deux à choisir. L'idée est qu'entre un rendement en dividendes élevé (meilleur), de solides perspectives de croissance du cours de l'action (plus rapide) et une valorisation attrayante (moins chère), vous trouverez des actions qui ne présentent jamais que deux de ces trois attributs. Ou pourrait-on trouver une exception qui...
Read more
0
Share
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade